BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 8827561)

  • 1. Office probing for congenital nasolacrimal duct obstruction: a study of parental satisfaction.
    Goldblum TA; Summers CG; Egbert JE; Letson RD
    J Pediatr Ophthalmol Strabismus; 1996; 33(4):244-7. PubMed ID: 8827561
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Office probing of congenital nasolacrimal duct obstruction.
    Stager D; Baker JD; Frey T; Weakley DR; Birch EE
    Ophthalmic Surg; 1992 Jul; 23(7):482-4. PubMed ID: 1407947
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Probing for nasolacrimal duct obstruction with intravenous propofol sedation.
    Movaghar M; Kodsi S; Merola C; Doyle J
    J AAPOS; 2000 Jun; 4(3):179-82. PubMed ID: 10849396
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Office- or Facility-Based Probing for Congenital Nasolacrimal Duct Obstruction: A Report by the American Academy of Ophthalmology.
    Morrison DG; Binenbaum G; Chang MY; Heidary G; Trivedi RH; Galvin JA; Pineles SL
    Ophthalmology; 2021 Jun; 128(6):920-927. PubMed ID: 33358412
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nasolacrimal Duct Probing under Topical Anesthesia for Congenital Nasolacrimal Duct Obstruction in Taiwan.
    Hung CH; Chen YC; Lin SL; Chen WL
    Pediatr Neonatol; 2015 Dec; 56(6):402-7. PubMed ID: 26026949
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical outcomes of initial and repeated nasolacrimal duct office-based probing for congenital nasolacrimal duct obstruction.
    Cha DS; Lee H; Park MS; Lee JM; Baek SH
    Korean J Ophthalmol; 2010 Oct; 24(5):261-6. PubMed ID: 21052504
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Office probing for treatment of nasolacrimal duct obstruction in infants.
    Miller AM; Chandler DL; Repka MX; Hoover DL; Lee KA; Melia M; Rychwalski PJ; Silbert DI; ; Beck RW; Crouch ER; Donahue S; Holmes JM; Quinn GE; Sala NA; Schloff S; Wallace DK; Foster NC; Frick KD; Golden RP; Lambert SR; Tien DR; Weakley DR
    J AAPOS; 2014 Feb; 18(1):26-30. PubMed ID: 24568978
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nasolacrimal duct office probing in children under the age of 12 months: Cure rate and cost evaluation.
    Le Garrec J; Abadie-Koebele C; Parienti JJ; Molgat Y; Degoumois A; Mouriaux F
    J Fr Ophtalmol; 2016 Feb; 39(2):171-7. PubMed ID: 26826746
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Factors affecting the success of nasolacrimal duct probing for congenital nasolacrimal duct obstruction.
    Mannor GE; Rose GE; Frimpong-Ansah K; Ezra E
    Am J Ophthalmol; 1999 May; 127(5):616-7. PubMed ID: 10334364
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy of Office-Based Nasolacrimal Duct Probing.
    Bach A; Vanner EA; Warman R
    J Pediatr Ophthalmol Strabismus; 2019 Jan; 56(1):50-54. PubMed ID: 30371916
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Success rates of probing for congenital nasolacrimal duct obstruction at various ages.
    Świerczyńska M; Tobiczyk E; Rodak P; Barchanowska D; Filipek E
    BMC Ophthalmol; 2020 Oct; 20(1):403. PubMed ID: 33032542
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Outcome of probing for congenital nasolacrimal duct obstruction in older children.
    Honavar SG; Prakash VE; Rao GN
    Am J Ophthalmol; 2000 Jul; 130(1):42-8. PubMed ID: 11004258
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pediatric nasolacrimal duct obstruction.
    Schnall BM
    Curr Opin Ophthalmol; 2013 Sep; 24(5):421-4. PubMed ID: 23846190
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Probing for congenital nasolacrimal duct obstruction in older children.
    Eshragi B; Fard MA; Masomian B; Akbari M
    Middle East Afr J Ophthalmol; 2013; 20(4):349-52. PubMed ID: 24339688
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Factors Associated With Nasolacrimal Duct Probing Failure Among Children in the Intelligent Research in Sight Registry.
    Oke I; Elze T; Miller JW; Lorch AC; Hunter DG; Elliott AT;
    JAMA Ophthalmol; 2023 Apr; 141(4):342-348. PubMed ID: 36862386
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intranasal endoscopic silicone intubation for congenital obstruction of the nasolacrimal duct in children.
    Orhan M; Onerci M
    Int J Pediatr Otorhinolaryngol; 1997 Sep; 41(3):273-8. PubMed ID: 9350486
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Management of congenital nasolacrimal duct obstruction--latin american study.
    Schellini SA; Ariki CT; Sousa RL; Weil D; Padovani CR
    Ophthalmic Plast Reconstr Surg; 2013; 29(5):389-92. PubMed ID: 23924988
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Congenital nasolacrimal duct obstruction.
    Robb RM
    Ophthalmol Clin North Am; 2001 Sep; 14(3):443-6, viii. PubMed ID: 11705144
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Evaluation of therapy outcome in congenital nasolacrimal duct obstruction in own material].
    Lipiec E; Grałek M; Niwald A
    Klin Oczna; 2006; 108(4-6):174-7. PubMed ID: 17019988
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Early office-based vs late hospital-based nasolacrimal duct probing. A clinical decision analysis.
    Kassoff J; Meyer DR
    Arch Ophthalmol; 1995 Sep; 113(9):1168-71. PubMed ID: 7661751
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.